UPDATE: Cryoport (CYRX) Misses Q3 EPS by 14c; Trims FY16 Revenue Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. DOX
4. VRTX
5. CHKP
6. CRWD
7. ON
8. INSP
9. HNGE
10. AMD

Go back to UPDATE: Cryoport (CYRX) Misses Q3 EPS by 14c; Trims FY16 Revenue Outlook

Cryoport Reports 50% Revenue Growth for the Third Quarter of Fiscal Year 2016

February 8, 2016 9:02 AM EST

IRVINE, Calif., Feb. 8, 2016 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company") today announced financial results for the three and nine-month periods ended December 31, 2015.

Commenting on the third quarter results, Jerrell Shelton, Chief Executive Officer of Cryoport, stated, "We grew revenue by 50% for the third quarter. This growth was primarily driven by the addition of a significant number of new biopharma clients, including eight new clinical trial programs.  Even though biopharma revenue was up 80% year-over-year, these results were well below our expectations due to delays in program... More